Ge, Zhen
Baber, Usman
Claessen, Bimmer E.
Chandrasekhar, Jaya
Chandiramani, Rishi
Li, Shawn X.
Sartori, Samantha
Kini, Annapoorna S.
Rao, Sunil V.
Weiss, Sandra
Henry, Timothy D.
Kapadia, Samir
Muhlestein, Brent
Strauss, Craig
Toma, Catalin
DeFranco, Anthony
Effron, Mark B.
Keller, Stuart
Baker, Brian A.
Pocock, Stuart
Dangas, George
Mehran, Roxana
Funding for this research was provided by:
Eli Lily and Co.
Daiichi Sankyo Inc.
Article History
First Online: 28 March 2019
Compliance with ethical standards
:
: We have the following financial disclosures to report: Dr. Mehran has received institutional grant support from The Medicines Company, Bristol-Myers Squibb/Sanofi, and Eli Lilly and Company/Daiichi Sankyo; and is a consultant to Abbott Vascular, AstraZeneca, Boston Scientific, Covidien, Janssen Pharmaceuticals, Regado Biosciences, Maya Medical, Merck & Co., and The Medicines Company. Dr. Kini serves on the speaker’s bureau of the ACC and has received consulting fees from WebMD. Dr. Henry has received research grant support from Eli Lilly and company, and Daiichi Sankyo. Mr. Keller is employed by Eli Lilly and Company and Dr. Effron is a shareholder and retiree of Eli Lilly and Company. Dr. Baker is employed by Daiichi Sankyo, Inc. All other authors report no relevant conflicts of interest.